The Usefulness of HyperQ Recordings for the Early Diagnosis of Acute Coronary Syndrome in Patients Presenting With Chest Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00339105|
Recruitment Status : Unknown
Verified January 2007 by Sheba Medical Center.
Recruitment status was: Recruiting
First Posted : June 20, 2006
Last Update Posted : January 17, 2007
|Condition or disease||Phase|
|Acute Coronary Syndrome||Phase 3|
Chest pain is the leading cause of urgent admission to the Emergency Department (ED) in western countries.Acute Coronary Syndrome(ACS) continues to be among the most difficult to predict or diagnose. Misdiagnoses may lead to discharge of patients with ACS, who should have been admitted as well as costly unnecessary hospitalizations of patients who do not have ACS.
To evaluate the usefulness of High Frequency mid-QRS analysis in identifying the ischemic patients out of all patients presenting to the Emergency Room (ER) with chest pain.
A continuous High Frequency Mid-QRS recording will be performed using the HyperQ System (BSP Ltd.) and compared to clinical, electrophysiologic and laboratory results. The golden standards used to compare the methods will be either CT-Angio, Echocardiography or Cardiac SPECT. A follow-up inquiry will be performed after 3 months and Coronary Angiography results will be sought and compared as well.
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Observational Model:||Defined Population|
|Official Title:||The Usefulness of HyperQ Recordings for the Early Diagnosis of Acute Coronary Syndrome in Patients Presenting With Chest Pain|
|Study Start Date :||June 2006|
|Estimated Study Completion Date :||January 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00339105
|Contact: Shlomi Matetzky, MDfirstname.lastname@example.org|
|The Chest Pain Unit, ER, Sheba Medical Center, Tel-Hashomer||Recruiting|
|Principal Investigator: Shlomi Matetzky, MD|
|Principal Investigator:||Shlomi Matetzky, MD||Head of Chest Pain Unit, ER, Sheba Medical Center|